GeneDx
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $76,874 | $70,514 | $62,422 | $57,418 |
Gross Profit | 47,829 | 38,542 | 32,979 | 25,575 |
EBITDA | -1,851 | -22,951 | -14,076 | -18,512 |
EBIT | -7,780 | -28,469 | -19,724 | -25,206 |
Net Income | -8,312 | -29,173 | -20,239 | -25,773 |
Net Change In Cash | 76,874 | 70,514 | 62,422 | 57,418 |
Free Cash Flow | -5,041 | -5,857 | -16,856 | -32,234 |
Cash | 57,894 | 56,076 | 83,673 | 99,681 |
Basic Shares | 27,095 | 26,617 | 26,062 | 25,978 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $202,566 | $234,694 | $212,195 | $179,322 |
Gross Profit | 60,622 | -26,750 | -16,602 | 4,026 |
EBITDA | -136,460 | -398,198 | -219,193 | -224,732 |
EBIT | -170,194 | -461,232 | -242,555 | -238,866 |
Net Income | -175,767 | -548,980 | -245,390 | -246,436 |
Net Change In Cash | 202,566 | 234,694 | 212,195 | 179,322 |
Cost of Revenue | -263,166 | |||
Free Cash Flow | -185,858 | -333,477 | -211,220 | -125,102 |
Cash | 99,681 | 123,933 | 400,569 | 108,132 |
Basic Shares | 24,311 | 10,236 | 3,275 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.04 |
2024-06-30 | -$0.10 |
2024-03-31 | -$0.33 |
2023-12-31 | -$0.69 |
